The American Academy of Dermatology annual meeting was packed with “massive advancements” across the field, Joel M. Gelfand, ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...

Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

Acitretin, isotretinoin, and ultraviolet B are less frequently used than other class I treatments for lichen planus, such as topical corticosteroids.

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...

Eli Lilly And Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) said adolescent patients with severe alopecia areata (AA) ...

Vitamin D, often called the "sunshine vitamin," is made when our skin absorbs UVB rays from the sun. These rays help our body ...

Positive results from ADEPT phase 2/3 study of Dupixent in adults with moderate-to-severe bullous pemphigoid presented at AAD: Paris Tuesday, March 11, 2025, 14:00 Hrs [IST] Posit ...

ORLANDO -- More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of ...

Lake Street analyst Ben Haynor lowered the firm’s price target on Sensus Healthcare (SRTS) to $13 from $18 and keeps a Buy rating on the shares ...

Results from the phase 3 ICONIC-LEAD study presented at this year’s American Academy of Dermatology (AAD) annual meeting ...